Pharmaron Beijing Ltd. Co.

In 2023, China was the second largest product/technology exporter in the global biopharmaceutical pipeline, with 143 pipeline transactions, runner up only to the US. In China’s biopharmaceutical indus

Business confidence within the Chinese biotech contract manufacturing sector is being shattered by the Biden Administration’s latest move to encourage investment in US domestic biotech manufacturing c

Beijing-based Jacobio Pharmaceuticals Co. Ltd. initiated two first-in-human studies in 2018 in China and the US for JAB-3312, and the start-up took its lead asset into Phase IIa just months later. T

Pharma and life science companies have had a busy October in Asia, unveiling a series of openings of manufacturing and R&D facilities in the region, particularly in China, to respond to growing local